Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome

Open access
Abraham, Aswin, Krasnodembskaya, Anna·2020·Stem Cells Translational Medicine

Abstract

Acute respiratory distress syndrome (ARDS) is a serious and potentially fatal acute inflammatory lung condition which currently has no specific treatments targeting its pathophysiology. However, mesenchymal stem cells have been shown to have very promising therapeutic potential, and recently, it has been established that their effect is largely due to the transfer of extracellular vesicles (EVs). EVs have been shown to transfer a variety of substances such as mRNA, miRNA, and even organelles such as mitochondria in order to ameliorate ARDS in preclinical models. In addition, the fact that they have been proven to have the same effect as their parent cells combined with their numerous advantages over whole cell administration means that they are a promising candidate for clinical application that merits further research. Significance statement Extracellular vesicles (EVs) are being actively explored as an alternative to whole-cell therapy. Acute respiratory distress syndrome is a devastating clinical condition with high mortality rate and no pharmacological treatment; therefore, novel therapies for this condition are critically needed. This review discusses preclinical studies where the therapeutic potential of mesenchymal stem cell (MSC) EVs was investigated in models of lung injury. Evidence suggests that MSC EVs demonstrate potent protective effects mediated through a variety of mechanisms related to the transfer of EVs cargo to the recipient cells. Further research into the mechanism of action, biodistribution, standardization, and biomanufacturing is needed to facilitate clinical translation of this exciting new cell therapy product.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/sctm.19-0205

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 160

Metadata

Authors
Abraham, A., & Krasnodembskaya, A.
Venue
Stem Cells Translational Medicine
Published
2019-10-24
Volume
9
Issue
1
Pages
28-38
ISSN
  • 2157-6564 (ISSN-L)
  • 2157-6580
OpenAlex
W2981426204
Cited by
160
References
11
FWCI
8.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. https://app.cochat.ai/papers/10.1002/sctm.19-0205
The paper
Abraham, A., & Krasnodembskaya, A. (2020). Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Translational Medicine. https://doi.org/10.1002/sctm.19-0205

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.